Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

Abstract Background Although clozapine is an effective option for treatment-resistant schizophrenia (TRS), there are still 1/3 to 1/2 of TRS patients who do not respond to clozapine. The main purpose of this randomized, double-blind, placebo-controlled trial was to explore the amisulpride augmentati...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi Li
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	KeAi Communications Co., Ltd. 2022-10-01
Schriftenreihe:	Military Medical Research
Schlagworte:	Schizophrenia Clozapine-resistant treatment refractory schizophrenia Clozapine Amisulpride Augmentation
Online-Zugang:	https://doi.org/10.1186/s40779-022-00420-0
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!